Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...
Vaxart is developing game-changing oral vaccines with the potential to redefine vaccine delivery and immune responses: Vaxart is advancing multiple vaccine programs across high-value markets, ...
This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the ...
An Indonesian researcher spotted fishy behaviour by her compatriots at a conference in Denmark and refused to look away. The ...
The Manila Times on MSN
Supreme Court upholds US birthright citizenship
WASHINGTON, D.C. — The United States Supreme Court on Tuesday rejected President Donald Trump’s bid to restrict birthright citizenship in a blow to one of his signature anti-immigration initiatives.
Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.
Mike O’Brien has a couple of memorable stories stretching from early in his childhood to just a month or so ago that ...
The US Supreme Court rejected Trump's bid to limit birthright citizenship, ruling 6-3 that all born on US soil are citizens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results